NCT05096416

Brief Summary

Infiltration of a surgically-placed hemodialysis vascular access (HVA) is recognized as a major contributor to the high hospital re-admission rate in dialysis-dependent patients. Three dimensional modeling has been demonstrated as a critical tool for procedurists in preparation for surgical interventions but no such modeling is yet available for dialysis specialists to avoid the common complication of HVA infiltration. Contrast enhanced magnetic resonance angiography (MRA) can be used to generate a three dimensional image data that could render a three dimensional resin-based model of a vascular access.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
3mo left

Started Jan 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Jan 2023Jul 2026

First Submitted

Initial submission to the registry

October 15, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 27, 2021

Completed
1.2 years until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

August 2, 2022

Status Verified

July 1, 2022

Enrollment Period

3.6 years

First QC Date

October 15, 2021

Last Update Submit

July 31, 2022

Conditions

Keywords

hemodialysisMagnetic resonance angiographythree-dimensional (3D) printed hemodialysis vascular modelVascular access complication

Outcome Measures

Primary Outcomes (1)

  • Quantify the number of dialysis treatments completed

    12 month

Secondary Outcomes (2)

  • Quantify the number of vascular access interventions over a 12-month period compared to controls

    12 month

  • Quantify annual hospitalization rate compared to controls

    12 month

Study Arms (2)

Control arm

NO INTERVENTION

Patients in this arm will have standard of care where they will be annulated by the palpation method by the dialysis technician and nurse.

Intervention arm

EXPERIMENTAL

Patients in this arm will have a three-dimensional (3D) printed vascular access model to assist the dialysis technician and nurse in cannulation.

Device: The three-dimensional (3D) printed hemodialysis vascular model

Interventions

The three-dimensional (3D) printed hemodialysis vascular model will be used as a guide map to cannulate the patients for hemodialysis and to minimize the risk of vascular access complications

Intervention arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with a surgically placed hemodialysis access which has been used in the last 90 days or is being prepared for use in the next 90 days

You may not qualify if:

  • Patients with only failed hemodialysis surgical access(es) that has/have not been used for \>90 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

Study Officials

  • Andrew Siedlecki, MD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andrew Siedlecki, MD

CONTACT

Aliza Anwar Memon, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine

Study Record Dates

First Submitted

October 15, 2021

First Posted

October 27, 2021

Study Start

January 1, 2023

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

August 2, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations